Leerink Partners Adjusts Illumina's Price Target to $155 From $170
MT NewswiresApr 12 07:48 ET
Stephens Sticks to Their Buy Rating for Illumina (ILMN)
TipRanksApr 11 04:16 ET
Illumina Analyst Ratings
BenzingaApr 10 15:29 ET
Illumina Analyst Ratings
BenzingaApr 10 08:36 ET
Illumina Analyst Ratings
BenzingaApr 9 09:30 ET
RBC Cuts Price Target on Illumina to $253 From $258, Keeps Outperform Rating
MT NewswiresApr 8 07:49 ET
Illumina Analyst Ratings
BenzingaMar 20 11:55 ET
Critical Insights From Illumina Analyst Ratings: What You Need To Know
BenzingaFeb 14 12:00 ET
Illumina Analyst Ratings
BenzingaFeb 14 11:21 ET
RBC Capital Reiterates Outperform on Illumina, Maintains $258 Price Target
BenzingaFeb 9 11:23 ET
Illumina Analyst Ratings
BenzingaFeb 9 11:19 ET
Baird Adjusts Price Target on Illumina to $146 From $144, Maintains Neutral Rating
MT NewswiresFeb 9 08:02 ET
RBC Capital Sticks to Its Buy Rating for Illumina (ILMN)
TipRanksJan 26 20:45 ET
Illumina Analyst Ratings
BenzingaJan 25 09:47 ET
Pfizer and Illumina Downgraded but Merck Can Deliver, Declares TD Cowen
InvestingJan 4 14:34 ET
Illumina Analyst Ratings
BenzingaJan 4 06:16 ET
Illumina Analyst Ratings
BenzingaDec 19, 2023 10:41 ET
RBC Trims Price Target on Illumina to $258 From $260 Amid Grail Divestment Plan, Keeps Outperform Rating
MT NewswiresDec 19, 2023 07:45 ET
Illumina Analyst Ratings
BenzingaDec 18, 2023 11:02 ET
Illumina (ILMN) Receives a Buy From Stifel Nicolaus
TipRanksDec 18, 2023 07:46 ET
No Data
No Data